News Content
Its most core official alias is the generic name, Exemestane. As an International Nonproprietary Name (INN), Exemestane is the global standard for this drug. Whether in drug inserts, clinical research literature, or on prescriptions, "Exemestane" is the standard term. For example, in breast cancer treatment guidelines, "exemestane combination therapy" is mentioned far more frequently than the brand name, Aromasin. This universal name ensures accurate global dissemination of medical information.https://www.fiercerawsource.com/steroid-finished/steroid-finished-tablets/stromusc-pills-25mg-aromasin-exemestane-100.html
In its R&D and production, it also once had its own unique code name. During Pfizer's development phase in the 1990s, the drug's internal designation was "FCE 24304." This code name frequently appears in early pharmacological experimental literature. For example, the first human study, published in the Journal of Clinical Oncology in 1995, was titled "Observation of the Efficacy of FCE 24304 in Advanced Breast Cancer," documenting its initial development data. During production in different countries, some pharmaceutical companies have assigned brand name variations. For example, parts of the EU used "Aromasin" as a localized brand name, synonymous with Aromasin but applicable only to specific markets.
In the context of fitness and hormone management, simplified names such as "Aromasin" and "Yixi" have emerged. Because fitness enthusiasts often use exemestane in conjunction with testosterone-based medications to control estrogen levels, the generic name "exemestane" has been simplified to "Yixi" for ease of communication, or the common name "Aromasin" (previously used in the domestic market) has been retained. However, it's important to note that these common names are not official and may vary depending on regional or social customs, leading to confusion. For example, some people confuse "Aromasin" with other anti-estrogen drugs, overlooking its core class as an "aromatase inhibitor."
Pharmaceutical experts point out, "Clarifying Aromasin's multiple names is fundamentally about understanding the entire drug development process, from the laboratory to the clinic. Whether it's a generic name, development code, or common name, accurately matching the chemical nature of "exemestane" is crucial to avoiding misdosing or misclassification of medications due to name confusion, which is crucial for both medical treatment and health management."
